SUPAX
Price
$24.22
Change
-$0.19 (-0.78%)
Updated
Jul 13 closing price
Net Assets
103.14M
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

SUPAX vs VFFSX

SUPAX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
SUPAX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUPAX is a Buy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. SUPAX (103M). VFFSX pays higher dividends than SUPAX: VFFSX (1.08) vs SUPAX (0.62). SUPAX was incepted earlier than VFFSX: SUPAX (26 years) vs VFFSX (10 years). SUPAX (1.00) is less costly to investors than VFFSX (0.01). SUPAX is a more actively managed with annual turnover of: 27.00 vs. VFFSX (2.00). SUPAX has a lower initial minimum investment than VFFSX: SUPAX (1000) vs VFFSX (5000000000). SUPAX annual gain was more profitable for investors over the last year : 25.08 vs. VFFSX (21.07). VFFSX return over 5 years is better than : 73.48 vs. SUPAX (31.63).
SUPAXVFFSXSUPAX / VFFSX
Total Expense Ratio0.730.017,300%
Annual Report Gross Expense Ratio1.000.0110,000%
Fund Existence26 years10 years-
Gain YTD12.43710.685116%
Front Load6%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets103M1.67T0%
Annual Yield % from dividends0.621.0857%
Returns for 1 year25.0821.07119%
Returns for 3 years73.3968.45107%
Returns for 5 years31.6373.4843%
Returns for 10 years106.52251.2142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6